Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ELI LILLY AND COMPANY Investing Cash Flow

ELI LILLY AND COMPANY (LLY) reported Investing Cash Flow of -$19.31 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05

  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$15.40B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.92B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.80B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.98B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for fiscal 2025 was -$10.97B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for fiscal 2024 was -$9.30B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for fiscal 2023 was -$7.15B.
  • ELI LILLY AND COMPANY net cash provided by (used in) investing activities for fiscal 2022 was -$3.76B.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 3 month as first filedNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 6 month as first filedNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 9 month as first filedNet Cash Provided by (Used in) Investing Activities 12 monthNet Cash Provided by (Used in) Investing Activities 12 month as first filed
2026-06-30-$15.40B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$19.31B
10-Q · filed 2026-08-05
-$22.11B
derived: sum of 3 quarters · filed 2026-08-05
-$25.10B
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$3.92B
10-Q · filed 2026-04-30
-$6.72B
derived: sum of 2 quarters · filed 2026-04-30
-$9.70B
derived: sum of 3 quarters · filed 2026-04-30
-$11.54B
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$2.80B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$5.79B
derived: sum of 2 quarters · filed 2026-02-12
-$7.62B
derived: sum of 3 quarters · filed 2026-08-05
-$10.97B
10-K · filed 2026-02-12
2025-09-30-$2.98B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$4.82B
derived: sum of 2 quarters · filed 2026-08-05
-$8.17B
10-Q · filed 2025-10-30
-$10.09B
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$1.83B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$5.19B
10-Q · filed 2026-08-05
-$5.19B
10-Q · filed 2025-08-07
-$7.11B
derived: sum of 3 quarters · filed 2026-08-05
-$11.11B
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$3.35B
10-Q · filed 2026-04-30
-$3.35B
10-Q · filed 2025-05-01
-$5.27B
derived: sum of 2 quarters · filed 2026-04-30
-$9.28B
derived: sum of 3 quarters · filed 2026-04-30
-$11.48B
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$1.92B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$5.93B
derived: sum of 2 quarters · filed 2026-02-12
-$8.12B
derived: sum of 3 quarters · filed 2026-02-12
-$9.30B
10-K · filed 2026-02-12
-$9.30B
10-K · filed 2025-02-19
2024-09-30-$4.00B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$6.20B
derived: sum of 2 quarters · filed 2025-10-30
-$7.38B
10-Q · filed 2025-10-30
-$10.31B
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30-$2.20B
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$3.38B
10-Q · filed 2025-08-07
-$6.30B
derived: sum of 3 quarters · filed 2026-02-12
-$9.38B
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31-$1.18B
10-Q · filed 2025-05-01
-$4.10B
derived: sum of 2 quarters · filed 2026-02-12
-$7.18B
derived: sum of 3 quarters · filed 2026-02-12
-$7.64B
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31-$2.92B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$6.01B
derived: sum of 2 quarters · filed 2026-02-12
-$6.46B
derived: sum of 3 quarters · filed 2026-02-12
-$7.15B
10-K · filed 2026-02-12
-$7.15B
10-K · filed 2024-02-21
2023-09-30-$3.08B
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
-$3.54B
derived: sum of 2 quarters · filed 2024-10-30
-$4.23B
10-Q · filed 2024-10-30
-$5.17B
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30-$459.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$1.15B
10-Q · filed 2024-08-08
-$2.09B
derived: sum of 3 quarters · filed 2025-02-19
-$3.05B
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31-$688.80M
10-Q · filed 2024-04-30
-$1.63B
derived: sum of 2 quarters · filed 2025-02-19
-$2.59B
derived: sum of 3 quarters · filed 2025-02-19
-$3.41B
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31-$943.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
-$1.90B
derived: sum of 2 quarters · filed 2025-02-19
-$2.73B
derived: sum of 3 quarters · filed 2025-02-19
-$3.76B
10-K · filed 2025-02-19
-$3.26B
10-K · filed 2023-02-22
2022-09-30-$955.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$1.78B
derived: sum of 2 quarters · filed 2023-11-02
-$2.82B
10-Q · filed 2023-11-02
-$2.40B
10-Q · filed 2022-11-01
-$3.30B
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30-$826.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$1.86B
10-Q · filed 2023-08-08
-$1.48B
10-Q · filed 2022-08-04
-$2.35B
derived: sum of 3 quarters · filed 2024-02-21
-$2.96B
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31-$1.04B
10-Q · filed 2023-04-27
-$1.01B
10-Q · filed 2022-04-29
-$1.52B
derived: sum of 2 quarters · filed 2024-02-21
-$2.14B
derived: sum of 3 quarters · filed 2024-02-21
-$2.62B
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31-$484.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
-$1.10B
derived: sum of 2 quarters · filed 2024-02-21
-$1.58B
derived: sum of 3 quarters · filed 2024-02-21
-$2.87B
10-K · filed 2024-02-21
-$2.76B
10-K · filed 2022-02-23
2021-09-30-$616.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
-$1.10B
derived: sum of 2 quarters · filed 2022-11-01
-$2.38B
10-Q · filed 2022-11-01
-$3.06B
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30-$483.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$1.77B
10-Q · filed 2022-08-04
-$2.44B
derived: sum of 3 quarters · filed 2023-02-22
-$2.75B
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31-$1.28B
10-Q · filed 2022-04-29
-$1.96B
derived: sum of 2 quarters · filed 2023-02-22
-$2.27B
derived: sum of 3 quarters · filed 2023-02-22
-$2.48B
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$674.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
-$987.60M
derived: sum of 2 quarters · filed 2023-02-22
-$1.20B
derived: sum of 3 quarters · filed 2023-02-22
-$2.26B
10-K · filed 2023-02-22
2020-09-30-$313.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
-$523.90M
derived: sum of 2 quarters · filed 2021-10-27
-$1.58B
10-Q · filed 2021-10-27
-$1.63B
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$210.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
-$1.27B
10-Q · filed 2021-08-03
-$1.31B
derived: sum of 3 quarters · filed 2022-02-23
-$1.74B
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$1.06B
10-Q · filed 2021-04-30
-$1.10B
derived: sum of 2 quarters · filed 2022-02-23
-$1.53B
derived: sum of 3 quarters · filed 2022-02-23
-$1.47B
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31-$41.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$465.20M
derived: sum of 2 quarters · filed 2022-02-23
-$404.20M
derived: sum of 3 quarters · filed 2022-02-23
-$8.08B
10-K · filed 2022-02-23
2019-09-30-$423.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28
-$362.80M
derived: sum of 2 quarters · filed 2020-10-28
-$8.04B
10-Q · filed 2020-10-28
-$8.70B
derived: sum of 4 quarters · filed 2021-02-17
2019-06-30$61.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
-$7.62B
10-Q · filed 2020-07-31
-$8.28B
derived: sum of 3 quarters · filed 2021-02-17
-$8.67B
derived: sum of 4 quarters · filed 2021-02-17
2019-03-31-$7.68B
10-Q · filed 2020-05-01
-$8.34B
derived: sum of 2 quarters · filed 2021-02-17
-$8.74B
derived: sum of 3 quarters · filed 2021-02-17
-$5.60B
derived: sum of 4 quarters · filed 2021-02-17
2018-12-31-$659.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
-$1.06B
derived: sum of 2 quarters · filed 2021-02-17
$2.08B
derived: sum of 3 quarters · filed 2021-02-17
$1.91B
10-K · filed 2021-02-17
2018-09-30-$398.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25
$2.74B
derived: sum of 2 quarters · filed 2019-10-25
$2.56B
10-Q · filed 2019-10-25
$4.22B
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$3.13B
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$2.96B
10-Q · filed 2019-08-02
$4.62B
derived: sum of 3 quarters · filed 2020-02-19
$2.86B
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31-$170.30M
10-Q · filed 2019-05-02
$1.48B
derived: sum of 2 quarters · filed 2020-02-19
-$275.40M
derived: sum of 3 quarters · filed 2020-02-19
-$2.52B
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$1.65B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
-$105.10M
derived: sum of 2 quarters · filed 2020-02-19
-$2.35B
derived: sum of 3 quarters · filed 2020-02-19
-$3.78B
10-K · filed 2020-02-19
2017-09-30-$1.76B
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$4.01B
derived: sum of 2 quarters · filed 2018-11-06
-$5.44B
10-Q · filed 2018-11-06
-$6.61B
derived: sum of 4 quarters · filed 2019-10-24
2017-06-30-$2.25B
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25
-$3.68B
10-Q · filed 2018-07-25
-$4.86B
derived: sum of 3 quarters · filed 2019-10-24
-$5.65B
derived: sum of 4 quarters · filed 2019-10-24
2017-03-31-$1.43B
10-Q · filed 2018-04-27
-$2.61B
derived: sum of 2 quarters · filed 2019-10-24
-$3.40B
derived: sum of 3 quarters · filed 2019-10-24
-$4.42B
derived: sum of 4 quarters · filed 2019-10-24
2016-12-31-$1.18B
derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24
-$1.97B
derived: sum of 2 quarters · filed 2019-10-24
-$2.99B
derived: sum of 3 quarters · filed 2019-10-24
-$3.14B
8-K · filed 2019-10-24
2016-09-30-$794.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
-$1.82B
derived: sum of 2 quarters · filed 2017-10-27
-$1.96B
10-Q · filed 2017-10-27
-$1.71B
derived: sum of 4 quarters · filed 2018-02-20
2016-06-30-$1.02B
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28
-$1.17B
10-Q · filed 2017-07-28
-$912.60M
derived: sum of 3 quarters · filed 2018-02-20
-$1.48B
derived: sum of 4 quarters · filed 2018-02-20
2016-03-31-$145.40M
10-Q · filed 2017-05-01
$108.30M
derived: sum of 2 quarters · filed 2018-02-20
-$461.80M
derived: sum of 3 quarters · filed 2018-02-20
-$279.40M
derived: sum of 4 quarters · filed 2018-02-20
2015-12-31$253.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20
-$316.40M
derived: sum of 2 quarters · filed 2018-02-20
-$134.00M
derived: sum of 3 quarters · filed 2018-02-20
$26.80M
10-K · filed 2018-02-20
2015-09-30-$570.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
-$387.70M
derived: sum of 2 quarters · filed 2016-10-28
-$226.90M
10-Q · filed 2016-10-28
-$2.41B
derived: sum of 4 quarters · filed 2017-02-21
2015-06-30$182.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
$343.20M
10-Q · filed 2016-07-28
-$1.84B
derived: sum of 3 quarters · filed 2017-02-21
-$3.49B
derived: sum of 4 quarters · filed 2017-02-21
2015-03-31$160.80M
10-Q · filed 2016-04-29
-$2.02B
derived: sum of 2 quarters · filed 2017-02-21
-$3.67B
derived: sum of 3 quarters · filed 2017-02-21
-$4.14B
derived: sum of 4 quarters · filed 2017-02-21
2014-12-31-$2.18B
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
-$3.83B
derived: sum of 2 quarters · filed 2017-02-21
-$4.30B
derived: sum of 3 quarters · filed 2017-02-21
-$3.91B
10-K · filed 2017-02-21
2014-09-30-$1.65B
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
-$2.12B
derived: sum of 2 quarters · filed 2015-10-30
-$1.73B
10-Q · filed 2015-10-30
-$2.96B
derived: sum of 4 quarters · filed 2016-02-19
2014-06-30-$468.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
-$80.50M
10-Q · filed 2015-07-30
-$1.31B
derived: sum of 3 quarters · filed 2016-02-19
-$2.26B
derived: sum of 4 quarters · filed 2016-02-19
2014-03-31$388.40M
10-Q · filed 2015-04-30
-$844.00M
derived: sum of 2 quarters · filed 2016-02-19
-$1.79B
derived: sum of 3 quarters · filed 2016-02-19
-$3.04B
derived: sum of 4 quarters · filed 2016-02-19
2013-12-31-$1.23B
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
-$2.18B
derived: sum of 2 quarters · filed 2016-02-19
-$3.43B
derived: sum of 3 quarters · filed 2016-02-19
-$2.07B
10-K · filed 2016-02-19
2013-09-30-$943.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29
-$2.20B
derived: sum of 2 quarters · filed 2014-10-29
-$840.40M
10-Q · filed 2014-10-29
-$2.50B
derived: sum of 4 quarters · filed 2015-02-19
2013-06-30-$1.25B
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28
$103.40M
10-Q · filed 2014-07-28
-$1.56B
derived: sum of 3 quarters · filed 2015-02-19
-$1.69B
derived: sum of 4 quarters · filed 2015-02-19
2013-03-31$1.36B
10-Q · filed 2014-04-28
-$307.40M
derived: sum of 2 quarters · filed 2015-02-19
-$440.10M
derived: sum of 3 quarters · filed 2015-02-19
-$825.40M
derived: sum of 4 quarters · filed 2015-02-19
2012-12-31-$1.66B
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19
-$1.80B
derived: sum of 2 quarters · filed 2015-02-19
-$2.18B
derived: sum of 3 quarters · filed 2015-02-19
-$2.83B
10-K · filed 2015-02-19
2012-09-30-$132.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
-$518.00M
derived: sum of 2 quarters · filed 2013-10-30
-$1.17B
10-Q · filed 2013-10-30
-$3.05B
derived: sum of 4 quarters · filed 2014-02-19
2012-06-30-$385.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26
-$1.04B
10-Q · filed 2013-07-26
-$2.91B
derived: sum of 3 quarters · filed 2014-02-19
-$3.92B
derived: sum of 4 quarters · filed 2014-02-19
2012-03-31-$652.30M
10-Q · filed 2013-04-26
-$2.53B
derived: sum of 2 quarters · filed 2014-02-19
-$3.54B
derived: sum of 3 quarters · filed 2014-02-19
-$5.44B
derived: sum of 4 quarters · filed 2014-02-19
2011-12-31-$1.88B
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19
-$2.89B
derived: sum of 2 quarters · filed 2014-02-19
-$4.78B
derived: sum of 3 quarters · filed 2014-02-19
-$4.82B
10-K · filed 2014-02-19
2011-09-30-$1.01B
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26
-$2.91B
derived: sum of 2 quarters · filed 2012-10-26
-$2.95B
10-Q · filed 2012-10-26
-$4.51B
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30-$1.90B
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27
-$1.94B
10-Q · filed 2012-07-27
-$3.50B
derived: sum of 3 quarters · filed 2013-02-21
-$4.29B
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31-$40.70M
10-Q · filed 2012-04-30
-$1.61B
derived: sum of 2 quarters · filed 2013-02-21
-$2.39B
derived: sum of 3 quarters · filed 2013-02-21
-$3.15B
derived: sum of 4 quarters · filed 2013-02-21
2010-12-31-$1.56B
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
-$2.35B
derived: sum of 2 quarters · filed 2013-02-21
-$3.11B
derived: sum of 3 quarters · filed 2013-02-21
-$3.16B
10-K · filed 2013-02-21
2010-09-30-$788.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
-$1.54B
derived: sum of 2 quarters · filed 2011-10-28
-$1.60B
10-Q · filed 2011-10-28
-$1.85B
derived: sum of 4 quarters · filed 2012-02-24
2010-06-30-$754.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29
-$806.80M
10-Q · filed 2011-07-29
-$1.06B
derived: sum of 3 quarters · filed 2012-02-24
-$993.40M
derived: sum of 4 quarters · filed 2012-02-24
2010-03-31-$52.60M
10-Q · filed 2011-04-29
-$306.90M
derived: sum of 2 quarters · filed 2012-02-24
-$239.20M
derived: sum of 3 quarters · filed 2012-02-24
-$137.10M
derived: sum of 4 quarters · filed 2012-02-24
2009-12-31-$254.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
-$186.60M
derived: sum of 2 quarters · filed 2012-02-24
-$84.50M
derived: sum of 3 quarters · filed 2012-02-24
$142.80M
10-K · filed 2012-02-24
2009-09-30$67.70M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-10-29
$169.80M
derived: sum of 2 quarters · filed 2010-10-29
$397.10M
10-Q · filed 2010-10-29
-$5.07B
derived: sum of 4 quarters · filed 2011-02-22
2009-06-30$102.10M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-02
$329.40M
10-Q/A · filed 2010-08-02
-$5.14B
derived: sum of 3 quarters · filed 2011-02-22
-$5.07B
derived: sum of 4 quarters · filed 2011-02-22
2009-03-31$227.30M
10-Q · filed 2010-07-30
-$5.24B
derived: sum of 2 quarters · filed 2011-02-22
-$5.17B
derived: sum of 3 quarters · filed 2011-02-22
2008-12-31-$5.47B
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22
-$5.39B
derived: sum of 2 quarters · filed 2011-02-22
-$7.27B
10-K · filed 2011-02-22
2008-09-30$71.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30
-$1.80B
10-Q · filed 2009-10-30
2008-06-30-$1.87B
10-Q · filed 2009-07-31
2007-12-31-$4.33B
10-K · filed 2010-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94